
Parean Biotechnologies is a next-generation service provider specializing in immune and tumor cell analysis for biotech and pharmaceutical companies. Founded in 2020 by experts from pharmaceutical industry, academic research, and biotech, the company offers an integrated technological platform combining advanced wet lab experiments (including cytometry, cell sorting, bulk and single-cell omics library generation) with AI-powered data science tools. Certified by 10x Genomics and ISO 9001, Parean focuses on oncology, immunotherapy, cell and gene therapies, auto-immunity, inflammation, and neuro-immunology. Their platform supports TCR-based discovery, immune repertoire analysis, and predictive bioinformatics, enabling clients to develop cell therapies, biologics, and biomarkers. The company has established partnerships, published over 20 scientific papers, and renewed key certifications and agreements through 2026, positioning it as a leader in immune-focused translational research and data-driven innovation.

Parean Biotechnologies is a next-generation service provider specializing in immune and tumor cell analysis for biotech and pharmaceutical companies. Founded in 2020 by experts from pharmaceutical industry, academic research, and biotech, the company offers an integrated technological platform combining advanced wet lab experiments (including cytometry, cell sorting, bulk and single-cell omics library generation) with AI-powered data science tools. Certified by 10x Genomics and ISO 9001, Parean focuses on oncology, immunotherapy, cell and gene therapies, auto-immunity, inflammation, and neuro-immunology. Their platform supports TCR-based discovery, immune repertoire analysis, and predictive bioinformatics, enabling clients to develop cell therapies, biologics, and biomarkers. The company has established partnerships, published over 20 scientific papers, and renewed key certifications and agreements through 2026, positioning it as a leader in immune-focused translational research and data-driven innovation.